SAMUEL D HOEPER

Allopathic & Osteopathic Physicians|Internal Medicine KANSAS CITY, MO NPI 1700877792

General Payments — all program years on this page

$2,978.04

  • Category: General Payments
  • Program years: PY2018–2022
  • Record count: 212
  • As of (CMS publication): 2026-01-23

Latest program year (PY2022): $350.80 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2022) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $350.8020

By paying entity

Latest program year (PY2022) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $739.4754
2019 $585.2949
2020 $346.3324
2021 $956.1565
2022 $350.8020

Records — PY2022 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
887714465 Boehringer Ingelheim Pharmaceuticals, Inc. $19.06 03/29/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
887714467 Boehringer Ingelheim Pharmaceuticals, Inc. $27.79 02/10/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892831573 ABBVIE INC. $27.41 04/18/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
892831577 ABBVIE INC. $20.61 07/08/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
893751371 Novartis Pharmaceuticals Corporation $14.98 04/27/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
893751375 Novartis Pharmaceuticals Corporation $16.20 02/07/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
902743053 Novo Nordisk Inc $14.60 03/31/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
914905499 AstraZeneca Pharmaceuticals LP $15.70 05/09/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
918280869 Lilly USA, LLC $22.96 05/14/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
918295297 Lilly USA, LLC $16.40 01/07/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
918330637 Lilly USA, LLC $16.40 01/14/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
918363931 Lilly USA, LLC $16.02 05/18/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
918363933 Lilly USA, LLC $17.05 05/27/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
920564177 Abbott Laboratories $15.80 04/12/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
932483585 E.R. Squibb & Sons, L.L.C. $15.54 01/11/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
939867633 Amgen Inc. $12.55 04/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
944418345 Merck Sharp & Dohme LLC $13.17 04/01/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
944419197 Merck Sharp & Dohme LLC $19.07 05/03/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
944797979 GlaxoSmithKline, LLC. $13.18 02/15/2022 Food and Beverage Undisputed 01/23/2026 View at CMS
949659349 PFIZER INC. $16.31 04/08/2022 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.